Here’s What Lays Ahead for Covid-19 Vaccines
Published in
Nov 17, 2020
--
As Jesse Smith reports, over the last week, news broke that Pfizer’s much anticipated Covid-19 vaccine was found to be 90% effective and Moderna reported that its Covid-19 vaccine is 94.5% effective. This news raised hopes of a vaccine being available by the end of 2020. Also over the past week the FDA granted emergency authorization for Eli Lilly’s monoclonal antibody therapy bamlanivimab. “News of these two therapies moving one step closer to availability shed a ray of hope on what is shaping up to be the most challenging phase of the pandemic,” writes Smith. “Before hopes rise too much, there are a few challenges that need to be addressed before these therapies are widely available.”
